首页> 外国专利> HUMANIZED HLA-A2 / HLA-DP4 TRANSGENIC MICE AND USES THEREOF AS AN EXPERIMENTAL MODEL FOR BIOMEDICAL RESEARCH AND DEVELOPMENT

HUMANIZED HLA-A2 / HLA-DP4 TRANSGENIC MICE AND USES THEREOF AS AN EXPERIMENTAL MODEL FOR BIOMEDICAL RESEARCH AND DEVELOPMENT

机译:人源化HLA-A2 / HLA-DP4转基因小鼠及其用途作为生物医学研究与开发的实验模型

摘要

The present invention concerns transgenic mice comprising non-functional H2 class and H2 class II genes and comprising a functional HLA-A2 transgene and a functional HLA-DP4 transgene. The present invention also relates to methods of identifying the presence of one or more epitopes in a candidate antigen or group of antigens, methods of determining the immune response of a mouse following its immunization with an antigen or a vaccine or following its treatment with an immunotherapeutic compound, methods of comparing the efficiency of a response induced by two or more vaccinal or immunotherapeutic compositions, and methods of determining whether a vaccinal or an immunotherapeutic composition poses a risk of induction of an autoimmune disease when administered to a human. The invention further concerns transgenic mouse cells comprising non-functional H2 class I and H2 class II genes and comprising a functional HLA-A2 transgene and a functional HLA-DP4 transgene, and kits for identifying the presence of one or more epitopes in a candidate antigen or group of antigens.
机译:本发明涉及包含非功能性H2类和H2类II基因并且包含功能性HLA-A2转基因和功能性HLA-DP4转基因的转基因小鼠。本发明还涉及鉴定候选抗原或一组抗原中一个或多个表位的存在的方法,确定小鼠用抗原或疫苗免疫后或用免疫治疗剂治疗后免疫应答的方法。化合物,比较由两种或更多种疫苗或免疫治疗组合物诱导的应答效率的方法,以及确定疫苗或免疫治疗组合物施用于人时是否具有诱发自身免疫性疾病风险的方法。本发明进一步涉及包含非功能性H2 I类和H2 II类基因并包含功能性HLA-A2转基因和功能性HLA-DP4转基因的转基因小鼠细胞,以及用于鉴定候选抗原中一种或多种表位的存在的试剂盒。或一组抗原。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号